Unknown

Dataset Information

0

Prasugrel Monotherapy After Percutaneous Coronary Intervention for Chronic Coronary Syndrome : Insights From ASET Pilot Studies

ABSTRACT:

SUBMITTER: Masuda S 

PROVIDER: S-EPMC10920039 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes.
| S-EPMC10018287 | biostudies-literature
Unknown Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Analysis from the Acute Coronary Syndrome Israeli Survey.
| S-EPMC9153328 | biostudies-literature
Unknown P2Y12 blocker monotherapy after percutaneous coronary intervention.
| S-EPMC8556441 | biostudies-literature
Unknown Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention.
| S-EPMC8183594 | biostudies-literature
Unknown Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy.
| S-EPMC8926957 | biostudies-literature
Unknown "Real-World" Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States.
| S-EPMC5215531 | biostudies-literature
Unknown P2Y<sub>12</sub> Inhibitor Monotherapy after Percutaneous Coronary Intervention.
| S-EPMC9604207 | biostudies-literature
Unknown Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial.
| S-EPMC8246339 | biostudies-literature
Unknown Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
| S-EPMC10685592 | biostudies-literature
Unknown Clinical Efficacy and Safety of Reduced-Dose Prasugrel After Percutaneous Coronary Intervention for Taiwanese Patients with Acute Coronary Syndromes.
| S-EPMC11642127 | biostudies-literature